v3.25.2
Note 5 - Stockholders' Equity
6 Months Ended
Jun. 30, 2025
Notes to Financial Statements  
Equity [Text Block]

5.

Stockholders Equity

 

Common Stock Transactions

 

March 2025 Offering. On March 25, 2025, we closed a registered direct offering of 1,350,000 shares of common stock, pre-funded warrants to purchase an aggregate of 2,085,115 shares of common stock, and common warrants to purchase up to 3,435,115 shares of common stock at an exercise price of $1.31 per share. Net proceeds after deducting placement agent commissions and other offering expenses were approximately $4.1 million. The pre-funded warrants were fully exercised during the second quarter of 2025.

 

ATM Program. On September 25, 2024, we entered into a Sales Agreement and established an “At-the-Market” continuous offering program (the “ATM Program”), pursuant to which the Company may offer and sell, from time to time through its sales agent, shares of its common stock. During the first quarter of 2025 we sold 1,952,603 shares of our common stock through the ATM Program for net proceeds of approximately $3.8 million, after deducting commissions to the sales agent and other related expenses. During the three months ended June 30, 2025, we sold no shares of our common stock through the ATM Program.

 

Stock Options

 

We have stock-based incentive plans (the “Plans”) pursuant to which our Board of Directors may grant stock options and other stock-based awards to our employees, directors and consultants. A total of 2,033,648 shares of our common stock are reserved for future issuance pursuant to the Plans, inclusive of outstanding stock options. A summary of the Company’s stock option activity during the six months ended June 30, 2025 is presented below.

   

Number

of Shares

   

Weighted-

Average

Exercise

Price

   

Weighted-

Average

Remaining

Contractual

Term (yrs)

   

Aggregate

Intrinsic

Value

 

Outstanding at December 31, 2024

    333,648     $ 12.71       8.6     $ 58,500  

Stock options granted

    805,300       2.48                  

Outstanding at June 30, 2025

    1,138,948     $ 5.48       9.1     $ -  

Exercisable at June 30, 2025

    117,905     $ 30.67       6.6     $ -  

 

Stock Purchase Warrants

 

A summary of the Company’s warrant activity during the six months ended June 30, 2025 is presented below.

   

Common Warrants

                 
   

Number

of Shares

   

Weighted-Average Exercise Price

   

Weighted-Average

Remaining Contractual Term (yrs)

   

Pre-Funded

Warrants --

Number

of Shares

   

Total

Warrants

 

Outstanding at December 31, 2024

    6,617,747     $ 5.13       4.6       -       6,617,747  

Warrants issued

    3,435,115       1.31               2,085,115       5,520,230  

Warrants exercised

    -       -               (2,085,115 )     (2,085,115 )

Outstanding at June 30, 2025

    10,052,862     $ 2.61       4.6       -       10,052,862  

 

The table below summarizes additional information concerning warrants outstanding as of June 30, 2025.

Issue Date

 

Number

of Shares

   

Exercise

Price

 

Expiration

September 2020

    159,781     $ 75.00  

September 2025

September 2021

    6,668       195.00  

September 2026

May 2024

    1,605,688       1.31  

May 2029

July 2024

    2,170,000       1.31  

January 2030

August 2024

    2,675,610       1.31  

March 2030

March 2025

    3,435,115       1.31  

June 2030

Outstanding at June 30, 2025

    10,052,862